Through a participatory process with all actors from the pharmaceutical sector led by the Ministry of Health based on a situation diagnosis, discussion was promoted and a consensus was reached that lead to approval of pharmaceutical policy through an administrative act such as a ministerial resolution, presidential decree, or law (e.g., Brazil, Colombia, Ecuador, Paraguay, the Dominican Republic and, more recently, Panama, where the policy has not yet been approved). In the case of the subregional policies, the policies of the Andean Community, MERCOSUR, and Central America are noteworthy.